New Drug ApprovalINOVIO Wins FDA Approval for VOCERYQ to Reduce RRP Surgeries INOVIO Wins FDA Approval for VOCERYQ to Reduce RRP Surgeries Read Post »
Clinical TrialsAer Therapeutics Reports Phase 2a Failure for Fexlamose in COPD Aer Therapeutics Reports Phase 2a Failure for Fexlamose in COPD Read Post »
Clinical TrialsRegeneron’s Libtayo Maintains DFS Benefit in Longer-Term C-POST Resul... Regeneron’s Libtayo Maintains DFS Benefit in Longer-Term C-POST Resul... Read Post »
Health TidingsFour Innovative Medicines Win 2026 International Prix Galien Awards for Pha... Four Innovative Medicines Win 2026 International Prix Galien Awards for Pha... Read Post »
New Drug ApprovalVertex Expands Casgevy Approval to Children Aged Five in the UK Vertex Expands Casgevy Approval to Children Aged Five in the UK Read Post »
Health TidingsAgios Receives Three-Month FDA Review Extension for Mitapivat in SCD Agios Receives Three-Month FDA Review Extension for Mitapivat in SCD Read Post »
Health TidingsNRx Secures FDA Approval for Preservative-Free Ketamine NRx Secures FDA Approval for Preservative-Free Ketamine Read Post »
Clinical TrialsSobi Reports Positive REDUCE-2 Results for Pozdeutinurad Sobi Reports Positive REDUCE-2 Results for Pozdeutinurad Read Post »
Clinical TrialsAcumen Reports Sabirnetug Failure Despite Amyloid Reduction Acumen Reports Sabirnetug Failure Despite Amyloid Reduction Read Post »
Health TidingsSetara Raises $90M to Advance STAR-0871 for CMT2C and Overactive Bladder Setara Raises $90M to Advance STAR-0871 for CMT2C and Overactive Bladder Read Post »
Clinical TrialsAlnylam’s Brezosiran Lowers Mutant Huntingtin by Up to 64% Alnylam’s Brezosiran Lowers Mutant Huntingtin by Up to 64% Read Post »
New Drug ApprovalSun’s ILUMYA Gains New FDA Indication Following INSPIRE Trials Sun’s ILUMYA Gains New FDA Indication Following INSPIRE Trials Read Post »
Health TidingsInnovent-Takeda’s IBI363 Shows Strong Response Rates in Lung and Gast... Innovent-Takeda’s IBI363 Shows Strong Response Rates in Lung and Gast... Read Post »
Clinical TrialsGeron Discontinues IMpactMF Trial After DMC Flags OS Endpoint Risk Geron Discontinues IMpactMF Trial After DMC Flags OS Endpoint Risk Read Post »
Health Tidings Mergers & AcquisitionsBioMarin, GC Biopharma and Hanmi Pharm Sign $475M Fabry Therapy Deal BioMarin, GC Biopharma and Hanmi Pharm Sign $475M Fabry Therapy Deal Read Post »
Clinical TrialsOSE’s Tedopi Shows Encouraging Survival Results in NSCLC Trial OSE’s Tedopi Shows Encouraging Survival Results in NSCLC Trial Read Post »
Clinical TrialsaTyr’s Efzofitimod Shows Mixed Results in Sarcoidosis aTyr’s Efzofitimod Shows Mixed Results in Sarcoidosis Read Post »
Clinical TrialsCervoMed Reports Mixed Findings for Neflamapimod in DLB CervoMed Reports Mixed Findings for Neflamapimod in DLB Read Post »
Health TidingsNovavax Earns $125M as Sanofi Advances Flu-COVID Vaccine Trial Novavax Earns $125M as Sanofi Advances Flu-COVID Vaccine Trial Read Post »
Health TidingsDren Bio Secures $350M for Dibotatug Late-Stage Development Dren Bio Secures $350M for Dibotatug Late-Stage Development Read Post »
Health TidingsIovance Reports 59.1% Response Rate With Lifileucel in mNSCLC Iovance Reports 59.1% Response Rate With Lifileucel in mNSCLC Read Post »
Health TidingsHUTCHMED Gains US FDA Orphan Status for ITP Drug HUTCHMED Gains US FDA Orphan Status for ITP Drug Read Post »
Health TidingsCoherus Reports 75% Response Rate with Tagmokitug in First-Line ESCC Coherus Reports 75% Response Rate with Tagmokitug in First-Line ESCC Read Post »
Clinical TrialsAscletis’ Oral ASC30 Delivers Up to 1.7% HbA1c Reduction Ascletis’ Oral ASC30 Delivers Up to 1.7% HbA1c Reduction Read Post »
Health TidingsExogenus Leads €13M EU Initiative to Advance Osteoarthritis Therapy Exogenus Leads €13M EU Initiative to Advance Osteoarthritis Therapy Read Post »
Clinical TrialsOno Advances ONO-1110 Despite Failed Pain Trial Endpoints Ono Advances ONO-1110 Despite Failed Pain Trial Endpoints Read Post »
Health TidingsPalvella Wins FDA Priority Review for QTORIN After Positive Phase 3 Results Palvella Wins FDA Priority Review for QTORIN After Positive Phase 3 Results Read Post »
Health TidingsGenmab Reports Significant Survival Benefit in LiGeR-HN1 Trial Genmab Reports Significant Survival Benefit in LiGeR-HN1 Trial Read Post »
Clinical TrialsHUTCHMED’s SAFFRON Shows Benefit from Adding Savolitinib After Osimertini... HUTCHMED’s SAFFRON Shows Benefit from Adding Savolitinib After Osimertini... Read Post »
Health Tidings Regulatory & Health PolicyFDA Outlines Single-BLA Framework for Rare Disease Gene Editing FDA Outlines Single-BLA Framework for Rare Disease Gene Editing Read Post »
Clinical TrialsHUTCHMED Reports 24.9-Month PFS With First-Line Savolitinib Combination HUTCHMED Reports 24.9-Month PFS With First-Line Savolitinib Combination Read Post »
Clinical TrialsBioNTech and DualityBio Report Modest PFS Gain but Higher ILD in Breast Can... BioNTech and DualityBio Report Modest PFS Gain but Higher ILD in Breast Can... Read Post »
Health Tidings Mergers & AcquisitionsNovocure to Evaluate TTFields With Verastem’s VS-7375 in Pancreatic Cance... Novocure to Evaluate TTFields With Verastem’s VS-7375 in Pancreatic Cance... Read Post »
Health TidingsAbbVie Submits Etentamig BLA After Response and PFS Gains AbbVie Submits Etentamig BLA After Response and PFS Gains Read Post »
Health TidingsJ&J’s RIPTAC Platform Shows 75% Response in Prostate Cancer J&J’s RIPTAC Platform Shows 75% Response in Prostate Cancer Read Post »
Clinical TrialsPrilenia Reports Functional and Survival Signals for Pridopidine in ALS Prilenia Reports Functional and Survival Signals for Pridopidine in ALS Read Post »
Clinical TrialsUroGen’s Five-Year Data Support Durable JELMYTO Responses UroGen’s Five-Year Data Support Durable JELMYTO Responses Read Post »
Clinical TrialsRetatrutide Delivers 20.9% Mean Weight Loss Against Semaglutide Retatrutide Delivers 20.9% Mean Weight Loss Against Semaglutide Read Post »
Health TidingsOctant Secures FDA Orphan Status for Its Retinitis Pigmentosa Drug Octant Secures FDA Orphan Status for Its Retinitis Pigmentosa Drug Read Post »
Clinical TrialsLynk Reports Positive 76-Week Zemprocitinib Results in Rheumatoid Arthritis Lynk Reports Positive 76-Week Zemprocitinib Results in Rheumatoid Arthritis Read Post »
Health Tidings Mergers & AcquisitionsAstellas and Audax Sign US$1.34 Billion Agreement for DAX-044 Astellas and Audax Sign US$1.34 Billion Agreement for DAX-044 Read Post »
Health TidingsIdorsia Starts Lucerastat Fabry Trial, Secures Nxera Deal Idorsia Starts Lucerastat Fabry Trial, Secures Nxera Deal Read Post »
Clinical TrialsAmgen Reports Phase 3 Success for Dazodalibep in Sjögren’s Disease Amgen Reports Phase 3 Success for Dazodalibep in Sjögren’s Disease Read Post »
Clinical TrialsGrünenthal Reports Sustained Pain Reduction With Qutenza Grünenthal Reports Sustained Pain Reduction With Qutenza Read Post »
Health TidingsFerring Adds Gameto’s Embryo Maturation Technology in Proposed $1.3825B D... Ferring Adds Gameto’s Embryo Maturation Technology in Proposed $1.3825B D... Read Post »
Health TidingsSyncromune Reports 80% Two-Year Survival With SYNC-T Therapy Syncromune Reports 80% Two-Year Survival With SYNC-T Therapy Read Post »
Clinical TrialsVanda Reports Positive Results for Tradipitant in GLP-1 Vomiting Vanda Reports Positive Results for Tradipitant in GLP-1 Vomiting Read Post »
Clinical TrialsBeam’s BEAM-301 Shows Early Metabolic Benefits in GSDIa Beam’s BEAM-301 Shows Early Metabolic Benefits in GSDIa Read Post »
Clinical TrialsArtiva Ends AlloNK Development After Durability Shortfall and Two Fatal Eve... Artiva Ends AlloNK Development After Durability Shortfall and Two Fatal Eve... Read Post »
Clinical TrialsPfizer Reports Positive PFS Results for ELREXFIO in RRMM Trial Pfizer Reports Positive PFS Results for ELREXFIO in RRMM Trial Read Post »